Date: 2.9.2019
Summary:
A German research team has demonstrated the link between Thrombospondin Type-1 Domain containing 7A Protein and various cancer types and presents a new way to use this tumor specific to improve cancer treatment efficiency by early diagnosis. Sought are industrial or institutional partners involved in the development and/or production of cancer biomarkers, cancer diagnosis/therapy, and research of cancer treatment for licensing, transfer of rights, knowledge transfer, or R&D cooperation.
Reference: TODE20190221001
Country: Germany
Submitted: 2. 9. 2019
Keywords
Technology: Applications for Health; Pharmaceutics; Diagnostics, Diagnosis
Market: In-vitro diagnostics; Molecular diagnosis; Therapeutic services
NACE: -
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology legislative - Biotech legislative environment search
Biotechnology events no 8 - Page 8 of our database of biotechnology events
New possibilities for the medical use of botulinun toxin A1
Mosquito-spreading drones could slash the spread of disease